Archives
-
Solanesol B8776: Practical Handling Guide
2026-09-17
Solanesol B8776 provides a defined polyisoprenoid alcohol for hydrophobic biochemical and membrane-related workflows where solvent compatibility and fresh preparation are important. It is suitable for selected research assays when prepared in DMSO, but it should not be used as an ethanol- or water-based preparation or for diagnostic, clinical, or medical purposes.
-
ω-Agatoxin IVA TFA: Cav2.1 Assay Logic
2026-09-17
ω-Agatoxin IVA TFA is a selective Cav2.1 tool for distinguishing calcium current, synaptic release, and downstream neuronal effects. This guide develops a causal assay framework from cardiac vagal electrophysiology to epilepsy animal model research without overextending channel-blockade results.
-
Primary Antibody Dilution Buffer for PCNSL IHC
2026-09-16
Use Primary Antibody Dilution Buffer K1200 to build more controlled IHC, ICC, and antibody-assisted ISH workflows for complex CNS lymphoma samples. This practical guide connects single-cell PCNSL biology with dilution design, tissue penetration, storage, controls, and troubleshooting without overstating what the product alone can validate.
-
MDM1, p53, and Chemoradiotherapy Sensitivity in CRC
2026-09-16
A 2025 Cancer Biology & Medicine study identifies MDM1 as a functional determinant of colorectal cancer chemoradiotherapy response. Its experiments connect MDM1 overexpression with reduced YBX1 occupancy at the TP53 promoter, increased p53 expression, and enhanced apoptosis, providing a mechanistic basis for biomarker-guided resistance research.
-
(1S,3R)-RSL3 glutathione peroxidase 4 inhibitor
2026-09-15
A practical, scenario-based guide to using SKU B6095 as a GPX4 inhibitor for ferroptosis research, with emphasis on assay interpretation, DMSO formulation, controls, and reproducible handling. The article connects product specifications with peer-reviewed evidence on lipid peroxidation, SLC7A11, PERK, and oncogenic RAS biology.
-
Lipidated Nanophotosensitizers Disable Tumor EVs
2026-09-15
A 2025 Nature Cancer study developed lipidated nanophotosensitizers that trace tumor extracellular vesicles and disable them under near-infrared irradiation. By generating reactive oxygen species in both tumor cells and tumor vesicles, the platform suppressed primary tumors while blocking vesicle-mediated communication associated with metastasis.
-
Tioconazole: Mechanism and Research Workflow
2026-09-14
Tioconazole is an antifungal medication and fungal cytochrome P450 inhibitor used in research on ergosterol biosynthesis and fungal infection models. Its defined identity, solubility profile, storage condition, and research-only status support controlled in vitro antifungal assays and antifungal drug development workflows.
-
VX-765 for Caspase-1 and Pyroptosis
2026-09-14
VX-765 provides a selective way to test whether caspase-1 drives cytokine release and pyroptotic injury rather than merely accompanying it. This guide translates endothelial-cell findings into practical workflows for inflammasome assays, macrophage studies, and inflammation-focused models while highlighting controls, handling requirements, and interpretation limits.
-
1-Phenyl-2-Pentanol in Hepatic Stellate Cells
2026-09-13
The reference study identifies 1-phenyl-2-pentanol from Moringa oleifera leaves as an in vitro inhibitor of TGF-β1-stimulated hepatic stellate cell activation. By combining fibrosis-marker profiling, proteomics, and molecular docking, the work connects reduced extracellular-matrix signaling with modulation of the TGF-β1 and Wnt/β-catenin pathways.
-
HOXC8, Caspase-1, and Pyroptosis in NSCLC
2026-09-12
The reference study identifies HOXC8 as a transcriptional suppressor of CASP1 expression that protects non-small cell lung carcinoma cells from caspase-1/GSDMD-mediated pyroptosis. Its findings connect transcription-factor activity, HDAC1/2 recruitment, inflammatory cell death, and tumor progression, while suggesting that targeted HOXC8 depletion may have therapeutic relevance.
-
Caspase-3 Colorimetric Assay Kit Guide
2026-09-11
The Caspase-3 Colorimetric Assay Kit measures DEVD-dependent caspase-3 activity in biological lysates through release of p-nitroaniline, providing a practical readout for apoptosis assays and related caspase activity measurement. It is intended for biochemical samples rather than live-cell imaging or in vivo studies, and its result should not be treated alone as proof of apoptosis or complete caspase pathway activation.
-
Z-IETD-FMK: Caspase-8 Inhibition Guide
2026-09-11
Z-IETD-FMK, also called Benzyloxycarbonyl-Ile-Glu(OMe)-Thr-Asp(OMe)-fluoromethylketone, is an irreversible caspase-8 inhibitor for apoptosis and immune cell activation research. Product evidence links it to activation-dependent T cell proliferation inhibition, CD25 downregulation, NF-κB signaling modulation, and reduced TRAIL-mediated apoptosis in defined experimental systems.
-
Z-IETD-FMK: Decoding Caspase-8 in Translation
2026-09-10
Z-IETD-FMK offers a pathway-focused way to interrogate caspase-8 in immune activation, apoptosis, and translational disease models. This thought-leadership guide connects T cell signaling and TRAIL biology with new evidence showing why mitochondrial caspase activity may correlate with cancer-associated muscle atrophy without causing it.
-
Z-VAD-FMK as a Causal Probe in Cancer
2026-09-10
Z-VAD-FMK is more than a pan-caspase blocker: it can function as a causal probe for separating apoptosis from autophagy in cancer models. This article translates recent UTMD pancreatic cancer findings into a rigorous assay strategy for apoptosis inhibition and pathway interpretation.
-
Z-WEHD-FMK in Caspase-1 Pyroptosis Research
2026-09-09
Z-WEHD-FMK, also known as Z-Trp-Glu(OMe)-His-Asp(OMe)-FMK, is a cell-permeable irreversible inhibitor used to interrogate inflammatory caspase signaling. Product information and peer-reviewed evidence support its use in Chlamydia infection models and in mechanistic studies of caspase-1-linked pyroptosis.